A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D005260:Female; D005340:Fibrinogen; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000235:genetics; D007258:Informed Consent; D007279:Injections, Subcutaneous; D007457:Iodine Radioisotopes; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications*; D013610:Tachycardia / Q000139:chemically induced; D013924:Thrombophlebitis / Q000175:diagnosis / Q000209:etiology; D013997:Time Factors
D007457:Iodine Radioisotopes; D005340:Fibrinogen; D006493:Heparin